Zobrazeno 1 - 10
of 123
pro vyhledávání: '"Koji Kuronuma"'
Autor:
Kosuke Tamura, Reiko Shimbashi, Ayu Kasamatsu, Bin Chang, Kenji Gotoh, Yoshinari Tanabe, Koji Kuronuma, Kengo Oshima, Takaya Maruyama, Masashi Nakamatsu, Shuichi Abe, Kei Kasahara, Junichiro Nishi, Yu Arakawa, Yuki Kinjo, Motoi Suzuki, Yukihiro Akeda, Kazunori Oishi
Publikováno v:
International Journal of Infectious Diseases, Vol 143, Iss , Pp 107024- (2024)
ABSTRACT: Objective: We aimed to investigate the impact of preceding seasonal influenza on the clinical characteristics of adult patients with invasive pneumococcal disease (IPD) in Japan. Methods: Data for 1722 adult patients with IPD were analyzed
Externí odkaz:
https://doaj.org/article/b0b4b56407ad46139a21efb68373d5a2
Autor:
Tatsuru Ishikawa, Hirotaka Nishikiori, Yuki Mori, Keiko Fujino, Atsushi Saito, Mamoru Takahashi, Koji Kuronuma, Shiro Hinotsu, Hirofumi Chiba
Publikováno v:
BMC Pulmonary Medicine, Vol 24, Iss 1, Pp 1-11 (2024)
Abstract Background Idiopathic pulmonary fibrosis (IPF) is a progressive disease with a poor prognosis. Pulmonary function tests (PFTs) aid in evaluating the disease status of IPF. The clinical significance of oscillometry measurements in interstitia
Externí odkaz:
https://doaj.org/article/02a9b6267fda44a782cee53fcbb5f3fc
Autor:
Yoshihiro Yokoyama, Tomoko Ichiki, Tsukasa Yamakawa, Yoshihisa Tsuji, Koji Kuronuma, Satoshi Takahashi, Eichi Narimatsu, Akio Katanuma, Hiroshi Nakase
Publikováno v:
Frontiers in Microbiology, Vol 15 (2024)
IntroductionPatients with COVID-19 have dysbiosis of the intestinal microbiota with altered metabolites in the stool. However, it remains unclear whether the differences among SARS-CoV-2 variants lead to differences in intestinal microbiota and metab
Externí odkaz:
https://doaj.org/article/d5985e9153074eaeadb96877708a5698
Autor:
Takehiro Hasegawa, Maho Yoshida, Shunsuke Watanabe, Takami Kondo, Hideo Asada, Atsushi Nakagawa, Keisuke Tomii, Masami Kameda, Mitsuo Otsuka, Koji Kuronuma, Hirofumi Chiba, Shinji Katayanagi, Yasunari Miyazaki, Akio Mori
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-9 (2023)
Abstract C–X–C motif chemokine ligand 9 (CXCL9), a candidate biomarker, reflects type 1 (T1) inflammation pathology. Here, we report the analytical performance and clinical characteristics of a new CXCL9 reagent for a fully automated immunoassay
Externí odkaz:
https://doaj.org/article/b5c2351e97f44236b2a89fcb5a634f70
Autor:
Bin Chang, Kosuke Tamura, Hiroyuki Fujikura, Hiroshi Watanabe, Yoshinari Tanabe, Koji Kuronuma, Jiro Fujita, Kengo Oshima, Takaya Maruyama, Shuichi Abe, Kei Kasahara, Junichiro Nishi, Tetsuya Kubota, Yuki Kinjo, Yusuke Serizawa, Reiko Shimbashi, Munehisa Fukusumi, Tomoe Shimada, Tomimasa Sunagawa, Motoi Suzuki, Kazunori Oishi, the Adult IPD Study Group
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-9 (2022)
Abstract We assessed the impact of the pediatric 13-valent pneumococcal conjugate vaccine (PCV13) on pneumococcal meningitis in adults in Japan in 2014–2018 by comparing epidemiological characteristics of adults with invasive pneumococcal disease w
Externí odkaz:
https://doaj.org/article/380b2bc9239147f99cfb7483a5c3c2cc
Autor:
Koji Kuronuma, Natsumi Susai, Tomohiro Kuroita, Hiroki Yamamoto, Takeshi Yoshioka, Shuji Kaneko, Hirofumi Chiba
Publikováno v:
ERJ Open Research, Vol 8, Iss 4 (2022)
Background Pirfenidone (PFD) is widely used in patients with idiopathic pulmonary fibrosis (IPF) and its adverse effects, such as nausea and photosensitivity, are well known. Many patients with IPF have reduced doses or even cessation of PFD because
Externí odkaz:
https://doaj.org/article/c99280ed6396454ba257778d6bf569c9
Autor:
Yoshihiro Yokoyama, Tomoko Ichiki, Tsukasa Yamakawa, Yoshihisa Tsuji, Koji Kuronuma, Satoshi Takahashi, Eichi Narimatsu, Hiroshi Nakase
Publikováno v:
Frontiers in Medicine, Vol 9 (2022)
IntroductionCoronavirus disease 2019 (COVID-19) is still causing a global pandemic. But the mechanism of COVID-19 severity is not well elucidated.Materials and methodsWe conducted two single-center observational studies of patients with COVID-19. In
Externí odkaz:
https://doaj.org/article/57f5726e270a4316825a4f87a7fc0ec5
Autor:
Reiko Shimbashi, Motoi Suzuki, Bin Chang, Hiroshi Watanabe, Yoshinari Tanabe, Koji Kuronuma, Kengo Oshima, Takaya Maruyama, Hiroaki Takeda, Kei Kasahara, Jiro Fujita, Junichiro Nishi, Tetsuya Kubota, Keiko Tanaka-Taya, Tamano Matsui, Tomimasa Sunagawa, Kazunori Oishi
Publikováno v:
Emerging Infectious Diseases, Vol 26, Iss 10, Pp 2378-2386 (2020)
The decline in the proportion of pneumococcal conjugate vaccine (PCV)–covered serotypes among adult invasive pneumococcal disease (IPD) patients might change the overall effectiveness of the 23-valent pneumococcal polysaccharide vaccine (PPSV23) be
Externí odkaz:
https://doaj.org/article/745611c55d59446f9658352c071f9642
Autor:
Takumi Yoshikawa, Mitsuo Otsuka, Hirofumi Chiba, Kimiyuki Ikeda, Yuki Mori, Yasuaki Umeda, Hirotaka Nishikiori, Koji Kuronuma, Hiroki Takahashi
Publikováno v:
BMC Pulmonary Medicine, Vol 20, Iss 1, Pp 1-11 (2020)
Abstract Background Idiopathic pulmonary fibrosis (IPF) is a progressive and fibrosing lung disease with poor prognosis. Pirfenidone and nintedanib are anti-fibrotic drugs used for patients with IPF. These drugs reduce the rate of decline in forced v
Externí odkaz:
https://doaj.org/article/a49cb8b527d44aa39d095a7b376741ac
Autor:
Tomofumi Kobayashi, Koji Kuronuma, Atsushi Saito, Kimiyuki Ikeda, Shigeru Ariki, Atsushi Saitou, Mitsuo Otsuka, Hirofumi Chiba, Satoshi Takahashi, Motoko Takahashi, Hiroki Takahashi
Publikováno v:
Respiratory Research, Vol 20, Iss 1, Pp 1-8 (2019)
Abstract Background The incidence of infectious disease caused by nontuberculous mycobacteria is increasing worldwide. Pulmonary Mycobacterium avium complex (MAC) disease is difficult to treat with chemotherapy, and its mechanism of infection, infect
Externí odkaz:
https://doaj.org/article/a66c24fe017342d9b35f1ce266443009